Share with others! EyeMelanoma.org quickly gets you to the info & resources you need.

EyeMelanoma.org

EyeMelanoma.orgEyeMelanoma.orgEyeMelanoma.org
  • Home
  • About
  • Organizations
  • Doctors
  • Diagnosis/Treatment
    • Diagnosis and Treatment
    • Research Opportunities
    • Journal Articles Search
    • Clinical Trials Search
  • Support
    • Financial Assistance
    • Personal Support
    • Facebook Groups
    • Mental Health Support
    • Patient Empowerment
    • Vision-Related Support
  • Conferences
  • Videos
  • More
    • Home
    • About
    • Organizations
    • Doctors
    • Diagnosis/Treatment
      • Diagnosis and Treatment
      • Research Opportunities
      • Journal Articles Search
      • Clinical Trials Search
    • Support
      • Financial Assistance
      • Personal Support
      • Facebook Groups
      • Mental Health Support
      • Patient Empowerment
      • Vision-Related Support
    • Conferences
    • Videos

EyeMelanoma.org

EyeMelanoma.orgEyeMelanoma.orgEyeMelanoma.org
  • Home
  • About
  • Organizations
  • Doctors
  • Diagnosis/Treatment
    • Diagnosis and Treatment
    • Research Opportunities
    • Journal Articles Search
    • Clinical Trials Search
  • Support
    • Financial Assistance
    • Personal Support
    • Facebook Groups
    • Mental Health Support
    • Patient Empowerment
    • Vision-Related Support
  • Conferences
  • Videos

OCULAR MELANOMA CONFERENCES: UPCOMING DATES PLUS VIDEOS OF PAST PRESENTATIONS

On this page, you will find:


  • Upcoming Dates for Ocular Melanoma Patient Conferences


  • Links to Videotaped Medical Presentations Made at Ocular Melanoma Patient Conferences During the Past Two Years


(NOTE: Links to recent OM-related educational videos that were not presented at a patient conference are posted on EyeMelanoma.org's Videos webpage.)

Upcoming Ocular Melanoma Patient Conferences

Upcoming patient conferences are updated here as information becomes available — such as a save-the-date announcement or a link to registration.


CURE OM's "2027 Eyes on a Cure Ocular Melanoma Patient & Caregiver Symposium" (16th Annual)

Early Details

When: Friday—Sunday, APRIL 16–18, 2027

Where: DENVER, COLORADO



Note: Ocumel Canada's Nov. 2026 Ocular Melanoma Patient & Caregiver Symposium "has been postponed [...] no new date in 2027 has been confirmed."


Free Videos of Past Ocular Melanoma Conference Presentations


Combined, these 12 Ocular Melanoma Patient Conferences from the past two years have posted more than 80 videotaped medical presentations online!



CLICK ON A CONFERENCE — 

EYEMELANOMA.ORG HAS COMPILED ALL THE DETAILS:

 EACH MEDICAL PRESENTATION'S TITLE, PRESENTER(S), VIDEO LENGTH, AND LINK TO WATCH IT.


A conference's host typically processes and posts its videotaped presentations on the internet within 4–8 weeks after a conference. 


Once the videos are available, a detailed list by EyeMelanoma.org of all the videotaped medical presentations and their links will be provided here.




Medical Presentations:


•   What's New in Uveal Melanoma Surveillance: Circulating Tumor DNA (CT DNA)

Panel Presenters: Christa Teller, Nurse (from Natera) and Claudia Scheckel, PhD (from Oncobit)  (35 minutes)


Early Disease —


•  What Happens After I Have Plaque or Proton Radiotherapy [as Primary Ocular Melanoma Treatment]? Managing Radiation Toxicity: Acute and Late Complications and Emerging Approaches to Symptom Control

Panel Presenters: Dr. Zelia Correa, Dr. Timothy Fuller, and Dr. William Harbour  (55 minutes)


•  Precision Diagnostics: Advances in Biomarkers for Early Detection and Personalized Care in Uveal Melanoma

Panel Presenters: Dr. Marcus Butler, Dr. Sanjay Chandrasekaran, Dr. Udai Kammula; and Dr. Alex Shoushtari  (50 minutes)


•  Adjuvant Therapy in Uveal Melanoma: Weighing Novel Agents Against Risk

Panel Presenters: Dr. Sanjay Chandrasekaran, Dr. William Harbour, Dr. Jose Lutzky, and Dr. Alex Shoushtari  (50 minutes) 



Metastatic/Advanced Disease —


•  Sequential and Combination Therapies in Metastatic Uveal Melanoma

Panel Presenters: Dr. Suandana Chandra, Dr. Gino In, Dr. Jose Lutzky, Dr. Alex Shoushtari  (50 minutes)


•  Liver-Directed Therapies for Metastatic Uveal Melanoma

Panel Presenters: Dr. Suandana Chandra, Dr. Sanjay Chandrasekaran, and Dr. Adrienne Shannon  

[Corrected Link Not Posted Yet]


•  Novel Immunotherapy and Targeted Therapy Strategies in Metastatic Uveal Melanoma

Panel Presenters: Dr. Marcus Butler, Dr. Gino In, Dr. Udai Kammula, and patient Sophie Cantu  (50 minutes)


All presentations






Medical Presentations:

Note: Timestamps show the beginning point of each presentation.


• Part 1 — Michael J. Mastrangelo Memorial Lecture


— Uveal Melanoma 2026: What We Know and What Is Ahead of Us

(Dr. Carol Shields; timestamp 9:55; 60 minutes)



• Part 2 — Presentations by MRIE Grant Awardees


Introduction

— Translational Research Strategies for Metastatic Uveal Melanoma

(Dr. Takami Sato; timestamp 4:20; 22 minutes)


Immunotherapy for Uveal Melanoma (Awardees 1–3; 10 minutes each)

— Cancer Vaccine Targeting for Uveal Melanoma 

(Award 1: Vitali Alexeev, PhD; timestamp 26:15)

— Immunotherapy of Metastatic Uveal Melanoma Using iPS Cell-Derived NK Cells (eNK cells) 

(Award 2: Mizue Terai, PhD; timestamp 36:20)

— Transgenic TCR-T Cell Production and Analysis [in Metastatic Uveal Melanoma]

(Award 3: Yuri Sykulev, PhD; timestamp 45:00)


Targeting the Signal Pathways in Metastatic Uveal Melanoma (Awardees 4–6; 10 minutes each)

— Targeting GNAQ/GNA11-Associated Signaling in Metastatic Uveal Melanoma

(Award 4: Philip Wedegaertner, PhD; timestamp 59:55)

— Pyroptosis and Lipid Metabolism in Uveal Melanoma

(Award 5: Claudia Capparelli, PhD; timestamp 1:09:50)

— Developing a Combo Treatment for Metastatic Uveal Melanoma [Therapeutic Implications of STING]

(Award 6: Haifeng Yang, PhD; timestamp 1:20:05)



• Part 3 — Evolving Clinical Approaches in Uveal Melanoma


— Neoadjuvant and Adjuvant Treatments for Primary Uveal Melanoma 

(Dr. Rino Seedor; timestamp 2:15; 25 minutes)


— Navigating Treatment Strategies in Metastatic Uveal Melanoma 

(Dr. Marlana Orloff; timestamp 27:05; 30 minutes)


— Selection of Liver-Directed Treatments for Hepatic Metastases [in Uveal Melanoma] 

(Dr. Robert Adamo; timestamp 57:10; 35 minutes)



•  Part 4 — Post-Diagnosis of Ocular Melanoma


— Benefits and Challenges of Clinical Trial Participation (Olivia Youman, Melanoma Clinical Research Manager; timestamp 26:30; 20 minutes, plus 20 minutes for Q&A with a patient's experience)



Also, non-medical presentations: 

•  In Part 4 — “Living Well with Ocular Melanoma: Navigating Practical and Emotional Needs” (Gregory Garber, MSW; first 25 minutes of video)

•  All of Part 5 — Updates from Patient Support Groups

Melanoma Research Foundation's CURE OM (timestamp 0:00); Melanoma Research Alliance (timestamp 14:37); A Cure in Sight (timestamp 28:40); and Eye on Grace Foundation (timestamp 36:50)






Note: For your convenience, EyeMelanoma.org has determined the starting time of each medical presentation within the larger video and pre-set the link to that starting point.


Saturday, Part 1 Video — Medical Presentations:


•   Understanding Uveal Melanoma  (Dr. Basil Williams, Jr.; pre-set to begin at 1:19:11 time stamp; 30 minutes)


•   Eye Plaque Treatment Planning  (Matthew Studenski, PhD; pre-set to begin at 1:51:46 time stamp; 10 minutes)


•   Proton Therapy for Ocular Melanoma: Current Practice and Future Directions (Dr. Roi Dagan; pre-set to begin at 2:02:05 time stamp; 10 minutes)


•   Belzupacap Sarotalocan (Bel-Sar) AU-011   (Dr. Brian Marr; pre-set to begin at 2:21:00 time stamp; 10 minutes)


•   Localized Treatment and Future Directions  (Panel discussion with all presenters; pre-set to begin at 2:30:49 time stamp; 40 minutes)


•   Eye Surveillance and Managing Side Effects [After Radiation Treatment of the Eye for Ocular Melanoma]"   (Dr. Maura Di Nicola; pre-set to begin at 3:09:07 time stamp; 30 minutes)



Saturday, Part 2 Video — Medical Presentations:


•   Seeing Risk Clearly: The Genetics of Uveal Melanoma Risk   (Dr. Nicholas Borja; pre-set to begin at 0:00 time stamp; 35 minutes)


•   Uveal Melanoma: Systemic Surveillance & Early Detection of Metastasis   (Dr. Leonel Hernandez-Aya; pre-set to begin at 33:39 time stamp; 30 minutes)


•   Preventing Recurrence in Uveal Melanoma; The Role of Adjuvant Therapies   (Dr. Jose Lutzky; pre-set to begin at 1:02:43 time stamp; 30 minutes)


•   Regional Therapies for Metastatic Uveal Melanoma   (Dr. Matthew Perez; pre-set to begin at 1:33:12 time stamp; 45 minutes)


•   Panel Discussion and Q&A with above presenters   (pre-set to begin at 2:18:22 time stamp; 15 minutes)


•   Clinical Trials and Innovation in Treatment [of Ocular Melanoma]   (Panel discussion with all presenters; pre-set to begin at 2:34:29 time stamp; 40 minutes)



Sunday Video — Medical Presentations:


•  Under the Microscope: Pathology Diagnosis of Ocular Melanoma  (Dr. Sander Dubovy; pre-set to begin at 2:55:10 time stamp; 40 minutes)



The Saturday Part 1 and Sunday videos also contain non-medical presentations for patients.






Medical Presentations:


• Session 1: Choroidal Melanoma [a type of uveal melanoma]  


— Choroidal Melanoma: Update on Prompt Diagnosis  (keynote presentation)

(Dr. David Ancona-Lezama; 75 minutes)



• Session 2: Radiation Oncology


— Eye Plaque Brachytherapy Treatment [for Uveal Melanoma] in Australia’s Sunshine State 

(Dr. Sarah Li; 15 minutes)


— Stereotactic Radiotherapy (Surgery) for Treatment of Posterior Choroidal Melanoma

(Dr. Claire Phillips; timestamp 14:15; 15 minutes)


— Q&A with above presenters (timestamp 31:15, 10 minutes)    



• Session 3: Latest Australian Ocular Melanoma Research


— Identifying the Roles of BAP1 in Uveal Melanoma 

(Vivian Chua, PhD; 15 minutes)


— Dealing with Uncertainty in the Context of Metastatic

Uveal Melanoma: A Qualitative Study

(Tim Luckett, PhD; timestamp 15:15; 15 minutes)


— Q&A with above presenters (timestamp 31:30; 10 minutes)  



• Session 4: Ocular Melanoma Clinical Trials and Therapies


— Bel-sar: Virus-Like Drug Conjugates as First-Line Treatment of Early-Stage Choroidal Melanoma  [Aura BioSciences presentation]

(Dr. Jill Hopkins; 20 minutes)


— Tebentafusp and Externally Sponsored Research for Ocular Melanoma  [Immunocore and Medison presentation]

(Jennifer Johansen; timestamp 19:15; 15 minutes)


— Uveal Melanoma: Australian Treatment Landscape

(Dr. Mal Ameratunga; timestamp 27:15; 15 minutes)


— Q&A with above presenters (timestamp 44:30; 15 minutes)


— Darovasertib Update for Ocular Melanoma  [Ideaya Biosciences presentation]

(Dennis Chang, PhD; timestamp 1:03:00, 10 minutes)






Medical Presentations:


• Ocular Surface Disease Associated with Treatment for Ocular Melanoma

(Dr. Johnson Yan Ning Neo; 25 minutes)


• CAM-Co-Culture: A Translational Model for Drug Discovery in Metastatic Uveal Melanoma

(Dr. Jayanti Jha; 15 minutes)


• Cancer Nutrition: What's Fact, What's Fiction, What Should We Really Eat?

(Dietician Jo Cunningham; 35 minutes)


• Care of Patients with Ocular Melanoma: Past, Present, and Future

(Dr. Bertil Damato; 40 minutes)



All videotaped presentations from this conference






Day 1 Video —


Medical Presentations:


• The Current Standards of Care for Ocular Melanoma: Conjunctival Melanoma and Uveal Melanoma 

(Dr. Hatem Krema; link pre-set to start time at 20:00; 50 minutes)


Day 1 includes other videotaped presentations from this symposium



Day 2 Video — 


Medical Presentations: 


• Optimizing Care for Metastatic Uveal Melanoma: Uveal Melanoma Updates from Society for Melanoma Research (SMR) and European Society for Medical Oncology (ESMO) 2025 Meetings 

(Dr. Marcus Butler, with Q&A facilitated by Dr. Alison Weppler; first 40 minutes of Day 2)


Day 2 includes other videotaped presentations from this symposium






Medical Presentations:


• Video 1: Keynote


— Yesterday, Today, and Tomorrow in Ocular Melanoma

(Dr. Miguel Materin; 40 minutes)



• Video 2 Topic: Ocular Melanoma After Treatment


— Your Vision Prognosis in Uveal Melanoma [After Plaque Brachytherapy]

(Dr. Arpita Maniar; 30 minutes)


— New Possible Ocular Treatments and Challenges

(Dr. Hakan Demirci; link set to its start at 28:50 timestamp; 20 minutes)



• Video 3 Topic: Liver-Directed Therapies for Metastatic Uveal Melanoma


— Liver-Directed Therapies for Metastatic Uveal Melanoma

(Dr. Vincent Ma; 20 minutes)


— Panel Discussion and Q&A on Liver-Directed Therapies

(Dr. Jennifer Atlas, Dr. Georgia Beasley, Dr. Vincent Ma, and Dr. Eric Mastria; link set to its start at 22:40 timestamp; 30 minutes)



• Video 4 Topic: The FDA and Research on Ocular Melanoma


— How Do the New FDA Guidelines Affect OM Research and My Care?

(Dr. Ross Goldstein and Nathalie Riebel; 50 minutes)



• Video 5 Topic: Metastatic OM Treatments & Clinical Trials


— Metastatic Treatments & Clinical Trials for Ocular Melanoma 

(Dr. April Salama; 25 minutes)


— Panel Discussion and Q&A on Metastatic Treatments & Clinical Trials

(Dr. Jennifer Atlas, Dr. Vincent Ma, and Dr. April Salama; link set to its start at 23:40 timestamp; 20 minutes)



• Video 6 Topic: Ocular Melanoma Biobank and Registry Updates


— Why Patient Data Is So Important: Tumor Tissue Donations at Pattern.org for Insight Biobank, Analytics at Pulse Infoframe, and Updates on Insight Patient Registry

(Melody Burchett, Ryan Sheedy, and Marshall Thompson, PhD; 50 minutes)



• Video 7 Topic: Novel Therapies in Uveal Melanoma


— Novel Therapies in Uveal Melanoma

(Dr. Meredith McKean; 25 minutes)


— Panel Discussion and Q&A on Novel Therapies in Uveal Melanoma

(Dr. Meredith McKean, Dr. Vincent Ma, and Dr. April Salama; link set to its start at 23:00 timestamp; 20 minutes)



• Video 10 Topic: Low Vision Rehabilitation 


— Visual Impact of Ocular Melanoma [and the Use of Vision Rehabilitation]

(Dr. Diane Whitaker; 50 minutes)



All videotaped presentations from this conference 






Medical Presentations:


• Morning Video (Part One)


— Uveal Melanoma: Evolving Approach in 2025

(Dr. Carol Shields; timestamp 14:15; 25 minutes)


— Eyes on the Future: What to Expect After Plaque Surgery for Uveal Melanoma

(Dr. Sara Lally; timestamp 39:15; 25 minutes)


— Q&A with above presenters (timestamp 1:03:00; 15 minutes)


— Radiographic Modalities for Follow-Up of Uveal Melanoma 

(Dr. Ashlesha Satish Udare; timestamp 1:19:45; 30 minutes) 



• Morning Video (Part Two)


— Loco-Regional Management of Liver Metastases from Ocular Melanoma

(Dr. Robert Adamo; timestamp 2:45; 35 minutes)


— Standard Care for Metastatic Uveal Melanoma

(Dr. Rino Seedor; timestamp 37:30; 20 minutes)


— Uveal Melanoma in Our Clinical Trials Era

(Dr. Marlana Orloff; timestamp 56:15; 30 minutes)


— Q&A with above presenters (timestamp 1:25:00; 10 minutes)



• Afternoon Video (Part Three)


— Scientific Advances for Uveal Melanoma

(Dr. Andrew Aplin; timestamp 2:15; 25 minutes)



• Afternoon Video (Part Four)


— Ocular Oncology Navigation

(Nurse Navigator Jameson Lynch; timestamp 2:30; 10 minutes)


— Participating in Ocular Melanoma Clinical Trials

(Katherine Senter and Olivia Youman; timestamp 42:00; 20 minutes)


— General Q&A with Dr. Marlana Orloff, Dr. Takami Sato, and Dr. Rino Seedor (timestamp 1:04:30; 25 minutes)






Medical Presentations:


Click on timestamp for start of presentation


5:16  “Ocular Melanoma: Biology, Epidemiology, Diagnosis, and Local Treatment”  (Dr. Andrew W. Stacey; 40 minutes)


47:17  “Proton Therapy for Ocular Melanoma”  (Dr. Jonathan Chen; 40 minutes)


1:28:57  “New Insights into Prognostic Testing for Uveal Melanoma: What You Need to Know”  (Dr. Prithvi Mruthyunjaya; 55 minutes)


2:22:11  “The Immunology of Uveal Melanoma”  (Lucinda Innes, PhD; 15 minutes)


2:35:23   “Promising Systemic Therapeutic Advances for Metastatic Ocular Melanoma”  (Dr. Evan T. Hall; 25 minutes)


3:02:26   “Liver-Directed Immunotherapy for Ocular Melanoma”  (Dr. Shailender Bhatia; 35 minutes)


3:36:58   The Adjuvant Debate: “An Argument for Adjuvant Therapy of Ocular Melanoma"  (Dr. Shailender Bhatia) followed right after by "The Case Against Routine Adjuvant Therapy for Ocular Melanoma"  (Dr. Evan T. Hall) (total time for both presentations: 35 minutes)






Medical Presentations:


•  Primary Uveal Melanoma (5 sessions; 85 minutes total):


— "Ocular Surveillance — Tumor Control"

 (Dr. Yehonatan Weinberger; begins at time stamp 0:00)


— "Vision Loss After Radiation Treatment (Radiation Retinopathy)"

(Dr. Arun Singh; begins at time stamp 7:15)


— "DNA Testing: Who, When, Why"

(Meghan DeBenedictis, Certified Genetic Counselor; begins at time stamp 20:15)


— "Systemic Surveillance — How?"

(Dr. John Suh; begins at time stamp 34:45)


— "Panel Q & A" (begins at time stamp 1:01:00)



• Metastatic Uveal Melanoma (4 sessions; 90 minutes total):


— "Liver-Directed Therapies"

(Dr. James Isaacs, begins at time stamp 0:00)


— "Immunotherapies and Targeted Therapies"

(Dr. Lucy Boyce Kennedy; begins at time stamp 19:00)


— "Tebentafusp in Practice"

(Dr. Shaheer Khan; begins at time stamp 54:00)


— "Panel Q & A" (begins at time stamp 1:17:00)



• "Adjuvant Therapies in Uveal Melanoma"

(Dr. Shaheer Khan; 35 minutes)


• "Uveal Melanoma: Era of Ocular Clinical Trials"

(Dr. Arun Singh; 20 minutes)


• "Uveal Melanoma: Am I Cured Yet?"

(Dr. Arun Singh; 20 minutes)


• "Under the Microscope: Pathology Diagnosis of Ocular Melanoma"

(Dr. Jennifer Brainard; 45 minutes)



All videotaped presentations from this conference






Medical Presentations:


Day 1 Video —


• Current Approaches to the Management of Metastatic Uveal Melanoma 

(Dr. Marcus Butler; 40:35 timestamp start; 45 minutes)


Day 1 includes other videotaped presentations from this symposium



Day 2 Video — 


• Genomic Testing for Uveal Melanoma

(Katherina Alsina, Ph.D.; 3:30 timestamp start; 20 minutes)


Day 2 includes other videotaped presentations from this symposium





 IN ORDER TO HIGHLIGHT THE LATEST INFORMATION ON MEDICAL-RELATED TOPICS, ONLY OCULAR MELANOMA CONFERENCE PRESENTATIONS MADE DURING THE PAST TWO YEARS STAY LISTED ON THIS WEBPAGE EACH MONTH

 New information added to this webpage: November 18, 2026

 All content and links to external sites re-verified on this webpage: June 20, 2026

Any comments or suggestions? Please e-mail: Erica@EyeMelanoma.org

  • Home
  • About
  • Organizations
  • Doctors
  • Diagnosis and Treatment
  • Research Opportunities
  • Journal Articles Search
  • Clinical Trials Search
  • Financial Assistance
  • Personal Support
  • Facebook Groups
  • Mental Health Support
  • Patient Empowerment
  • Vision-Related Support
  • Conferences
  • Videos

EyeMelanoma.org, a not-for-profit U.S.-based website, does not contain any advertisements/sponsors and does not accept funding/donations.

Medical Disclaimer: This site is for informational purposes only and does not provide medical advice.

Focus Area: Ocular Melanoma Eye Cancer — Both Uveal Melanoma and Conjunctival Melanoma.
Copyright © 2011–2026.  EYEMELANOMA.ORG.  All Rights Reserved.